Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population

Exclusion Criteria

• •Undertaking high intensity exercise training and or undertaking more than 3 days of resistance training per week.
• •Serious illness(1) e.g., mood disorders such as depression, anxiety or bipolar disorder, neurological disorders such as MS, kidney disease, liver disease or heart conditions
• •Unstable illness(2) e.g., diabetes and thyroid gland dysfunction
• •Unstable intake of any medication or supplement(3)
• •Acute injuries on reporting area
• •Current malignancy (excluding Basal Cell Carcinoma) or chemotherapy or radiotherapy treatment for malignancy within the previous 2 years
• •Currently taking Coumadin (Warfarin), Heparin, Dalteparin, Enoxaparin or other anticoagulation therapy including low dose aspirin
• •Receiving medications known to affect inflammation such as steroids
• •Active smokers, nicotine use or drug (prescription or illegal substances) abuse
• •Chronic past and/or current alcohol use (\>21 alcoholic drinks per week)
• •Pregnant or lactating women
• •Allergic to any of the ingredients in active or placebo formula
• •Participants who are currently participating in any other clinical trial or who have participated in any other clinical trial during the past 1 month
• •Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
• •1. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.
• •2. An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity.
• •3. An unstable intake is any dose that has changed by more than 10% of the previous dose in the past 4-weeks